HomeComparePTE vs EQR

PTE vs EQR: Dividend Comparison 2026

PTE yields 20912.86% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PTE wins by $81743643826372870144.00M in total portfolio value
10 years
PTE
PTE
● Live price
20912.86%
Share price
$0.24
Annual div
$50.40
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$81743643826372870144.00M
Annual income
$80,981,894,292,535,550,000,000,000.00
Full PTE calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — PTE vs EQR

📍 PTE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPTEEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PTE + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PTE pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PTE
Annual income on $10K today (after 15% tax)
$1,777,593.43/yr
After 10yr DRIP, annual income (after tax)
$68,834,610,148,655,210,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, PTE beats the other by $68,834,610,148,655,210,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PTE + EQR for your $10,000?

PTE: 50%EQR: 50%
100% EQR50/50100% PTE
Portfolio after 10yr
$40871821913186435072.00M
Annual income
$40,490,947,146,267,780,000,000,000.00/yr
Blended yield
99.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

PTE
Analyst Ratings
8
Buy
5
Hold
1
Sell
Consensus: Buy
Price Target
$1.00
+314.9% upside vs current
Range: $1.00 — $1.00
Altman Z
-44.1
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PTE buys
0
EQR buys
0
No recent congressional trades found for PTE or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPTEEQR
Forward yield20912.86%4.73%
Annual dividend / share$50.40$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$81743643826372870144.00M$40.5K
Annual income after 10y$80,981,894,292,535,550,000,000,000.00$3,819.61
Total dividends collected$81693400766216093696.00M$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold
Analyst price target$1.00$70.35

Year-by-year: PTE vs EQR ($10,000, DRIP)

YearPTE PortfolioPTE Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$2,101,986$2,091,286.39$11,248$547.57+$2.09MPTE
2$413,076,745$410,827,619.58$12,701$666.53+$413.06MPTE
3$75,895,025,125$75,453,033,007.71$14,405$814.59+$75895.01MPTE
4$13,037,343,348,491$12,956,135,671,607.02$16,413$999.84+$13037343.33MPTE
5$2,093,969,922,274,026$2,080,019,964,891,140.80$18,795$1,232.92+$2093969922.26MPTE
6$314,463,669,699,286,140$312,223,121,882,452,900.00$21,639$1,527.95+$314463669699.26MPTE
7$44,157,379,181,838,770,000$43,820,903,055,260,530,000.00$25,057$1,903.80+$44157379181838.74MPTE
8$5,798,076,105,195,996,000,000$5,750,827,709,471,428,000,000.00$29,197$2,385.87+$5798076105195996.00MPTE
9$711,915,452,184,400,000,000,000$705,711,510,751,840,300,000,000.00$34,250$3,008.70+$711915452184400000.00MPTE
10$81,743,643,826,372,860,000,000,000$80,981,894,292,535,550,000,000,000.00$40,467$3,819.61+$81743643826372870144.00MPTE

PTE vs EQR: Complete Analysis 2026

PTEStock

PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.

Full PTE Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this PTE vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PTE vs SCHDPTE vs JEPIPTE vs OPTE vs KOPTE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.